# L_2023057EN.01000301.xml

| 23.2.2023 | EN | Official Journal of the European Union | L 57/3 |
| --- | --- | --- | --- |

23.2.2023

EN

Official Journal of the European Union

L 57/3

---

DECISION OF THE EEA JOINT COMMITTEE No 31/2020

of 20 March 2020

amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement [2023/345]

THE EEA JOINT COMMITTEE,

Having regard to the Agreement on the European Economic Area (“the EEA Agreement”), and in particular Article 98 thereof,

Whereas:

| (1) | Commission Implementing Regulation (EU) 2019/676 of 29 April 2019 approving the low-risk active substance ABE-IT 56 (components of lysate of Saccharomyces cerevisiae strain DDSF623), in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market, and amending the Annex to Commission Implementing Regulation (EU) No 540/2011 (1) is to be incorporated into the EEA Agreement. |
| --- | --- |

(1)

Commission Implementing Regulation (EU) 2019/676 of 29 April 2019 approving the low-risk active substance ABE-IT 56 (components of lysate of Saccharomyces cerevisiae strain DDSF623), in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market, and amending the Annex to Commission Implementing Regulation (EU) No 540/2011 (1) is to be incorporated into the EEA Agreement.

| (2) | Annex II to the EEA Agreement should therefore be amended accordingly, |
| --- | --- |

(2)

Annex II to the EEA Agreement should therefore be amended accordingly,

HAS ADOPTED THIS DECISION:

Article 1

Chapter XV of Annex II to the EEA Agreement shall be amended as follows:

| 1. | The following indent is added in point 13a (Commission Implementing Regulation (EU) No 540/2011):






  ‘— | 32019 R 0676: Commission Implementing Regulation (EU) 2019/676 of 29 April 2019 (OJ L 114, 30.4.2019, p. 12).’ |
| --- | --- | --- |

1.

The following indent is added in point 13a (Commission Implementing Regulation (EU) No 540/2011):

‘—

32019 R 0676: Commission Implementing Regulation (EU) 2019/676 of 29 April 2019 (OJ L 114, 30.4.2019, p. 12).’

| 2. | The following point is added after point 13zzzzzzzzzz (Commission Implementing Regulation (EU) 2019/717):






  ‘13zzzzzzzzzza. | 32019 R 0676: Commission Implementing Regulation (EU) 2019/676 of 29 April 2019 approving the low-risk active substance ABE-IT 56 (components of lysate of Saccharomyces cerevisiae strain DDSF623), in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market, and amending the Annex to Commission Implementing Regulation (EU) No 540/2011 (OJ L 114, 30.4.2019, p. 12).’ |
| --- | --- | --- |

2.

The following point is added after point 13zzzzzzzzzz (Commission Implementing Regulation (EU) 2019/717):

‘13zzzzzzzzzza.

32019 R 0676: Commission Implementing Regulation (EU) 2019/676 of 29 April 2019 approving the low-risk active substance ABE-IT 56 (components of lysate of Saccharomyces cerevisiae strain DDSF623), in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market, and amending the Annex to Commission Implementing Regulation (EU) No 540/2011 (OJ L 114, 30.4.2019, p. 12).’

Article 2

The text of Implementing Regulation (EU) 2019/676 in the Icelandic and Norwegian languages, to be published in the EEA Supplement to the Official Journal of the European Union, shall be authentic.

Article 3

This Decision shall enter into force on 21 March 2020, provided that all the notifications under Article 103(1) of the EEA Agreement have been made (*).

Article 4

This Decision shall be published in the EEA Section of, and in the EEA Supplement to, the Official Journal of the European Union.

Done at Brussels, 20 March 2020.

For the EEA Joint Committee

The President

Clara GANSLANDT

---

(1)  
  OJ L 114, 30.4.2019, p. 12.

1

(*)  No constitutional requirements indicated.

*

---